Shares of Catalyst Pharmaceuticals jumped 2.59% to $3.69 at 13:40 EST on Monday, after two consecutive sessions in a row of losses. NASDAQ Composite is rising 0.46% to $13,605.42, after four consecutive sessions in a row of gains. This seems, so far, a somewhat positive trend exchanging session today.

Catalyst Pharmaceuticals’s last close was $3.60, 42.97% under its 52-week high of $5.28.

Catalyst Pharmaceuticals’s Sales

Catalyst Pharmaceuticals’s sales growth is 0.8% for the current quarter and 5.5% for the next. The company’s growth estimates for the ongoing quarter is 12.5% and a drop 20% for the next.

Catalyst Pharmaceuticals’s Revenue

Year-on-year quarterly revenue growth declined by 5.1%, now sitting on 118.18M for the twelve trailing months.

Volatility

Catalyst Pharmaceuticals’s last day, last week, and last month’s average volatility was a negative 1.94%, a positive 0.40%, and a positive 0.13%, respectively.

Catalyst Pharmaceuticals’s last day, last week, and last month’s high and low average amplitude percentage was 3.69%, 4.25%, and 4.14%, respectively.

Catalyst Pharmaceuticals’s Stock Yearly Top and Bottom Value

Catalyst Pharmaceuticals’s stock is valued at $3.69 at 13:40 EST, way under its 52-week high of $5.28 and way higher than its 52-week low of $2.55.

Catalyst Pharmaceuticals’s Moving Average

Catalyst Pharmaceuticals’s worth is above its 50-day moving average of $3.54 and higher than its 200-day moving average of $3.58.

LEAVE A REPLY

Please enter your comment!
Please enter your name here